Last checked at 
(Alliance News) - Oxford BioDynamics PLC said on Friday it has signed a lease agreement for new laboratory and office space, significantly expanding its UK facilities.
The Oxford Business Park premises will house its growing UK infrastructure operations and follows the recent launches of its Covid Severity Test and Explorer Array Kit.
The biotechnology firm highlighted that the larger space will allow it "to operate independent processing lines for commercial test development and product support, biomarker discovery contracts, clinical trial support and internal R&D projects."
The company expects development work to be completed in late July 2021. 
"This new lease comes at an exciting time for Oxford Biodynamics, following the launch of both our prognostic test for COVID-19 severity and the EpiSwitch Explorer Array Kit. It marks the next important step of the continued roll-out of our expanded strategic focus," said Chief Executive Jon Burrows.
Oxford Biodynamics shares were trading at 89.00 pence in London at midday on Friday, down 4.3%.
By Will Paige; willpaige@alliancenews.com
Copyright 2021 Alliance News Limited. All Rights Reserved.
